key: cord-0722063-29vps1ek
authors: Gogolewski, Krzysztof; Miasojedow, Błażej; Sadkowska-Todys, Małgorzata; Stepień, Małgorzata; Demkow, Urszula; Lech, Agnieszka; Szczurek, Ewa; Rabczenko, Daniel; Rosińska, Magdalena; Gambin, Anna
title: Data-driven case fatality rate estimation for the primary lineage of SARS-CoV-2 in Poland
date: 2022-01-24
journal: Methods
DOI: 10.1016/j.ymeth.2022.01.006
sha: daa77c656efa8e810a8a74274a3bab7cb0af5a8b
doc_id: 722063
cord_uid: 29vps1ek

After more than one and a half year since the COVID-19 pandemics outbreak the scientific world is constantly trying to understand its dynamics. In this paper of the case fatality rates (CFR) for COVID-19 we study the historic data regarding mortality in Poland during the first six months of pandemic, when no SARS-CoV-2 variants of concern were present among infected. To this end, we apply competing risk models to perform both uni- and multivariate analyses on specific subpopulations selected by different factors including the key indicators: age, sex, hospitalization. The study explores the case fatality rate to find out its decreasing trend in time. Furthermore, we describe the differences in mortality among hospitalized and other cases indicating a sudden increase of mortality among hospitalized cases at the end of the 2020 spring season. Exploratory and multivariate analysis revealed the real impact of each variable and besides the expected factors indicating increased mortality (age, comorbidities) we track more non-obvious indicators. Recent medical care as well as the identification of the source contact, independently of the comorbidities, significantly impact an individual mortality risk. As a result, the study provides a twofold insight into the COVID-19 mortality in Poland. On one hand we explore mortality in different groups with respect to different variables, on the other we indicate novel factors that may be crucial in reducing mortality. The later can be coped, e.g. by more efficient contact tracing and proper organization and management of the health care system to accompany those who need medical care independently of comorbidities or COVID-19 infection.

As the epidemic of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) unfolds, the case fatality rates (CFRs) of COVID-19 are still being debated and research is ongoing on how to best predict severe course of the disease.

The first estimates provided by the World Health Organization (WHO) [1] and China [2] suggested that the CFR ranges between 3.4% and 5.8%. However, it now became quite clear that the observed CFR may differ considerably not only by country [3, 4] but also by the variants of SARS-CoV-2 [5, 6] .

In 2020, for the original SARS-CoV-2 strain, a couple of varying CFR estimates were presented on the national level for the first phase of outbreaks, e.g. estimates made for Italy, indicated a much higher fatality rate than in China [7] , but CFR observed in Germany was already lower (1.2%) [8] . Some of these differences were subsequently attributed to the different age distributions in Asian and European countries as the age specific CFRs appeared to be more in line [9, 10] . However, in 2021 over longer time span, the fatality rate of the SARS-CoV-2 in China was reported to decrease to 0.7% (95% CI 0.4-1.0%) [11] , while German update showed an important agedependent increase to approximately 7.5% during the epidemic peak [12] . Finally, a study for hospitalized cases in Brazil presented a decreasing trend over time of CFR from 31.8% (March 2020) to 18.2% (October 2020) [13] .

In addition, as many cases are in fact asymptomatic or pauci-symptomatic they may go undetected, depending on local testing policies [14] . In fact, in a large multi-country overview the observed CFRs were negatively correlated with the testing frequency [15] . As already exemplified, adjusting the CFR to account for undetected cases may substantially lower the estimates [16, 17] .

As opposed to the fatality rate among the diagnosed cases, the rate of deaths among all infected individuals, including those who never developed symptoms, was termed infection fatality rate (IFR). IFR estimates usually require additional data on the true rate of infections, such as data coming from seroprevalence studies. The IFR estimates based on this method in 2020 were reported of order 0.3% -0.7% [18, 19] , while later the aforementioned German study estimated IFR between 1.5% and 3.5%. [12] . Of note, even if the IFR represents more closely the biological process, still heterogeneity between countries is expected relating for e.g. to age distribution of cases or efficiency of health care system provision [18] . Studying individual level predictors of IFR is often difficult due to lack of representative samples of infected individuals and therefore more evidence is available at the level of predictors of the outcomes among the diagnosed cases.

While a number of predictors of the severe course of SARS-CoV-2 have been identified, there still remain open questions. Both IFR and CFR increase with age and are impacted by coexisting chronic conditions [20, 21] . The relation with age is consistent across practically all studies and the risk is slightly higher among men. Deaths are sporadic among children and young adults, but increase from the age of about 50 and the IFR is estimated to reach 8% -15% at the age of 80 or above [22, 23, 16] . Among chronic conditions the strongest predictors of poor outcomes tend to be the cardiovascular diseases -especially coronary heart disease, congestive heart failure and cerebrovascular disease, but also hypertension, diabetes and obesity [21, 24, 20, 25] . Other diseases found to deteriorate the clinical course include chronic respiratory diseases, chronic kidney diseases and malignancies [26] .

Finally, there remains a matter of genetic diversity of SARS-CoV-2. As of August 2021 four variants of concern (VoC) are spread around the world [27] . Their transmissibility is reported to increase in contrast to the primary virus linage [28, 29] and the effectiveness of vaccines in use is lower than against the original strain of the virus [30] . Even though the spread of SARS-CoV-2 B.1.1.7 (Alpha) and B.1.617.2 (Delta) VoC is observed worldwide, their severity is constantly being studied. Latest reports, however, consequently prove that the severity of COVID-19 caused by the original (non-VoC) SARS-CoV-2 strain [5, 31] . Importantly for our study, it was confirmed that the first non-outbreak of the Alpha VoC was detected in the UK on September 2020, while its outbreak subvariant was detected on December 2020 [32] .

In addition to the dependency on the variant, severity of the disease may also depend on coinfections with other viral and bacterial respiratory pathogens. Bacterial co-infections appear to worsen the prognosis of viral pneumonias and there is already some evidence that this is also the case in COVID-19 pneumonia [33, 34] . Worse prognosis was also observed in influenza coinfected patients [35] . The frequency of co-infections noted so far was not high [33] , but some of these infections display strong seasonality and their impact may be higher in the winter season.

We aim at estimating CFR for Poland over first six months after the outbreak, when only the original strain of SARS-CoV-2 was present in the population. We investigate the possible trends by the time period, differences by age and other key factors influencing CFR levels. During the period of analysis the testing strategy remained stable, targeting testing people who were in contact with a confirmed or probable case as well as individuals presenting with COVID-19 compatible symptoms, especially with severe acute respiratory infection. In addition, screening during outbreaks was also in place. Other non-pharmaceutical measures were variable over the time period [36, 37] .

Therefore, in order to understand the possible confounding factors in terms of temporal changes of the affected populations we characterize the cases by the infection context. In addition we include is considered more complete. The next section describes all the methods used in the presented work. Moreover, for convenience of the reader and more readability they are also visualized as a workflow diagram in Figure 1 .

SARS-CoV-2 genomic data. The analyzed genomic data comes from GISAID database (as of July To assess the genetic distance among samples a phylogenetic tree was built for randomly selected set of sequences form Poland and other European countries. The Bayesian phylogenetic tree was created using BEAST2 software (R wrapper babette) using the MCMC method, the HKY nucleotide substitution model, strict molecular clock, and the a priori Coalescent Exponential Population model [41] .

Epidemiological data. For the purpose of this work, the initial date for calculation of survival was defined as the date of onset of symptoms for symptomatic cases and the date of laboratory positive test results for asymptomatic cases. In case the onset date was unknown, the earlier of the date of the first positive laboratory test result and the date of clinical visit was recorded as the initial date. We defined the follow-up time as the time until death of any cause or the date, when the recovery was registered. For unresolved cases the censoring date was set as the last date the status was recorded or, if this date was missing, the date the case was interviewed or the date the record was last modified. All preprocessing transformations of the raw data that were made to perform the statistical analyses are listed in the Table ST1 .

Additionally, it should be emphasized, that the clinical symptoms were collected through checkboxes. Therefore, if the field was not completed (a symptom was not reported), but the patient was not coded as asymptomatic or the patient was hospitalized or the patient died -the symptoms were re-encoded as missing (not available, NA) values. This correction was introduced in order to better understand the distribution of symptoms, however, we cannot preclude any further misclassification.

We decided to use the competing risk model for the survival analysis. The multi-state models after one event occurs another may occur according to a given transition probability. On the contrary, in our situation we deal with two possible outcomes (death and recovery) and we observe the time only the first of them. One way of modeling competing risks employs standard methods of survival analysis for all risks separately treating other events as censored. This approach, however, is not relevant in most applications as it requires independence of risks. Hence we applied the methodology from [42, 43] , i.e. the generalized Cox model of competing risks. We assume a proportional hazards model for the subdistribution of the competing risk, which was in our case death.

Therefore, the advantages of our approach are twofold. Not only we by-pass the independence of risks, but also we investigate the covariates' effect on the cumulative incidence function and, as a result, we infer the absolute risk of the studied outcome over time. This approach was postulated as the most appropriate for investigating COVID-19 CFR [44, 45, 46, 47] .

In case the for some covariate patterns the observation time is shorter than the expected time needed to leave the system the estimated probability of death will be underestimated. In our study this is especially true for the most recent time periods. To overcome this issue we introduce a correction in the spirit of Ghani [48] .

While Ghani uses two separate models for two outcomes treating the other one as a censoring event, we estimate them in the competing risk model. However, as the next step we introduce the similar correction as follows. Using this method the CFR is calculated with the formula:

whereθ 0 andθ 1 are cumulative hazards for death and recovery at the maximum observation time,

respectively. Both of these were estimated as cumulative incidence functions from competing risks data [49] . Confidence intervals for both probability of fatality, probability of recovery and CFR are estimated using non-parametric bootstrap with 1000-fold resampling [50] . Competing risks proportional hazard regression [43] was used to investigate factors related to fatality rates.

The models were applied to all cases data and separately to the hospitalized cases only. The idea of the second analysis was that the registration and data collection of cases requiring hospitalisation should be more complete regardless of testing strategies or local shortages Some of possibly important covariates suffered from a large proportion of missing values (NAs).

We therefore used multiple imputations of missing covariates by substantive model compatible fully conditional specification. This method is a modification of multiple imputations by chained equations developed by Bartlett et al. [51] , in particular for competing risks models, and implemented in R package smcfcs [52] . Finally, the results are aggregated to determine the multivariate risk values based on the methods implemented in R package mitools [53] . Alongside, the univariate risk values were calculated using functions provided by Fine and Gray [42] and implemented in the R cmprsk package [54] . Based on the provided genomic data we confirm that the all of the surveillance data gathered in our study were infected by the non-VoC SARS-CoV-2 strain. Figure 2 in Poland concern the non-VoC SARS-CoV-2 strain.

The characteristics of infections were not stable over time. Initially, a substantial share of cases occurred among health care workers, which declined by week 19. During weeks 19 -22 there was a substantial increase in the proportion of cases among coal mine workers. This increase coincided with a larger proportion of asymptomatic cases and the smallest proportion of elderly people. The proportion of cases, for whom no contact with a confirmed case was identified increased over time and so did the proportion of cases infected in the contexts other than household or the working place (see Supplementary Fig. S1 ).

Majority of cases who died reported the typical COVID-19 symptoms such as fever, cough and dyspnea (Fig. 3) . Among cases who recovered, 5,959 (40.39%) were asymptomatic -had The percent in each cell corresponds to the fraction of patients of given sex and outcome that showed a given symptom, e.g. the value in the first row in the first column is understood as 49.93% of all cases who have censored outcome were symptomatic (showed some symptoms). The analogous figure describing symptoms among different age groups as well as onset months can be found in the Supplementary Fig. S2 Table 2 : Estimated hazard ratios for factors associated with an increased CFR based on both multi-and univariate risk analysis performed on imputed data. The results are presented for: all (upper table) and hospitalized  (bottom table) 

We estimate the case fatality rate (CFR) in a large cohort of patients in Eastern Europe, demonstrating comparable values to the previously reported levels in other countries. We confirm the strong association of the CFR with the age group and co-existing conditions. In addition, we quantify the effect of the summer season on the CFR.

CFR shows significant differences between countries. It is influenced by such factors as: the age structure of the society, the wealth of the economy, the quality and efficiency of the healthcare system. Adequate measures taken by state authorities such as lockdown, massive testing and efficient strategies for contact tracking can significantly reduce CFR. In case of polish data, the estimated CFR value decreased from 7.83% to 2.52% with respect to infection period (March-April, July-August, respectively). Additionally, the determined decreasing trend is in accordance with the study by Ghayda et al. [55] were the time evolution of CFR in the several-month period after the outbreak is emphasized. Similarly, a study in Germany finds a decrease during the summer [12, 56] .

Interestingly, a study in Italy found no difference in CFR over the time [57] . Possible seasonality in the risk of severe course of COVID-19 is still not clear, but our findings as well as findings in Germany, are consistent with such hypothesis.

We found a 67.8% relative decrease in the estimated CFR during the spring and especially summer months. The case fatality rate as opposed to the infection fatality rate may depend on the testing policy, which is reflected in the possibility of the system to detect all the infections, not only the severe ones. Testing strategies comprised testing of the persons with severe acute respiratory infection and other symptoms suggestive of COVID-19, testing of quarantined people, screening of selected health care workers as well as testing of exposed individuals during identified outbreaks, mainly at work places. However, although we note that the composition of occupational groups as well as of the main transmission risks vary considerably between the analysed periods, they do not display a clear tendency, which could explain the decrease in CFR, when corrected for the age of the cases. Moreover, in our analysis we correct for this effect by including in the analysis the variable identifying for which cases the source of infection was known. As expected the CFR for cases with known source was lower indicating better case ascertainment, especially for milder cases. In addition, a similar pattern was noted for cases that needed hospital admission, for whom the testing criteria were stable. Finally, the fatality rates decreased in multiple European countries, with different testing systems, making this explanation less likely. We hypothesize that the decrease could in fact be caused by lower virulence of the virus during the warmer periods of time which is in line with the findings of Spena et al. [58] . Other possible factor to take into account is lower incidence of other respiratory infections. A recent study shows that coinfection with another respiratory virus was a 2.7-fold (1. 22-5.83 ) higher risk of fatal outcome [59] .

Beside the possible CFR seasonality, improvement of the survival among hospitalized cases points to better clinical management. While initially all cases were hospitalized this lasted only during the initial 2 weeks of the epidemic. At latter stages home isolation was preferred for less severe cases. In addition the hospital resources during this first wave of epidemic were not exceeded.

This leads to a conclusion that admission criteria remained comparable throughout the study pe- Limitations.. The data quality was not sufficient to run more elaborate analysis including the impact of comorbidities. Since the data was based on routinely collected data the information was not rich enough to attempt imputation of missing values for specific comorbidities. Disturbance of taste and smell was re-coded from text fields which could explain low percent of cases for whom this symptom was reported. Furthermore, we noted a very long time until recovery. The average of over 30 days is related to the strict criteria until the case may be considered recovered. During the time period included in the analysis 2 negative tests with 24h were required before the case was considered recovered. Later evidence suggested that this requirement was not necessary and the recommendations were adjusted accordingly. On the other hand, we only considered recovery from acute disease. Long COVID-19 was not considered.

In the presented work we provide an insight into the CFR levels as well as time to recovery/death estimates in Poland, in the first six months of COVID-19 epidemics, which was caused exclusively by the original strain of SARS-CoV-2. The survival analysis methodology used in the study is based on the competing risk regression along with corrections suggested by Ghani [48] , which provide robust and reliable estimates of epidemiological COVID-19 risk factors. The work points out that the CFR does not only depend on already known factors i.e. age, sex or comorbidities, but also is influenced by the recent need of medical care and possibly identification of a contact source. Moreover, we show that the summer months are characterized by a significantly lower CFR than other seasons. The natural extension of this work is a consequence of novel variants of concern, which requires analogous analyses to be performed among patients infected by specific The numeric value was categorized according to the national policies implemented during the first wave of epidemics in Poland. infection period Disease start dates are categorized into two-months infection periods corresponding to: (i) the first wave, (ii) post-wave period, (iii) summer period; that differed in centrally imposed NPIs. occupation

Each occupation from the raw data was categorized into one of the following: (i) health care, (ii) other, (iii) not working (adult), (iv) child. recent medical care

To reduce the correlation of the variable with health care related occupation, all subjects working in health care have this variable set to "No". contact source

The original contact source was binarized into two categories: (i) Documented (e.g. travel to affected country, contact at work, etc.), (ii) None identified. Figure 4 from the main text of the article. Figure S1 : Percentage distribution of confirmed cases for different factors for the first six months after the COVID-19 outbreak in Poland. It is likely, that the large difference between the effect of the time period Jun-Aug in both multivariate and univariate analysis (multivariate: 0.95 (0.83-1.09), p=0.4689, univariate: 0.77 (0.67-0.88) is explained by the different demographic structure of patients in different time periods. For instance the cases in March-April were on average older than in subsequent time periods. In addition, these were more often patients infected in health care (outbreaks in hospitals and long-term care facilities). This caused the CFR to be larger during Mar-Apr. Yet, correcting for these factors the CFR becomes comparable between the two time periods. Figure S2 : Frequency of reported symptoms, by outcome (Recovery, Death, Censored) and by age (less than 65, 65-75, more than 75). The percent in each cell corresponds to the fraction of patients of given age with a specified outcome that showed a selected symptom, e.g. the value in the first row in the first column is understood as 47.49% of infected younger than 65 years old who have censored outcome were symptomatic (showed some symptoms). Figure S3 : Frequency of reported symptoms, by outcome (Recovery, Death, Censored) and by infection period (March-April, May-June, July-August). The percent in each cell corresponds to the fraction of patients who were infected in a given period with a specified outcome that showed a selected symptom, e.g. the value in the first row in the first column is understood as 60% of cases from March-April period who have censored outcome were symptomatic (showed some symptoms). Figure S4 : Survival plots during the first six months of COVID-19 epidemic in Poland. Two panels visualize the adapted Kaplan-Meier method applied to all (left) and hospitalized (right) cases data. In each panel, the red stripes describe the probability of fatality, the blue ones the probability of recovery (or 1 -probability on the combined plots), both as a function of disease duration time. In both cases the line represents a mean estimated value, while the shade the 0.95 confidence interval. One can notice that approximately 3 times higher CFR characterized severe cases of COVID-19 that required hospitalization.

World Health Organization, Who director-general's opening remarks at the media briefing on covid

Estimating the instant case fatality rate of COVID-19 in China

Hennig, H. Sacks, Early epidemiological indicators, outcomes, and interventions of COVID-19 pandemic: A systematic review

Estimation of novel coronavirus (COVID-19) reproduction number and case fatality rate: A systematic review and meta-analysis

Sars-cov-2 variants of concern and variants under investigation in englandtechnical briefing 18

Case fatality risk of the SARS-CoV-2

Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

Covid-19: Why Germany's case fatality rate seems so low

Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China

Monitoring trends and differences in COVID-19 case-fatality rates using decomposition methods: Contributions of age structure and age-specific fatality

Transmission dynamics and control measures of COVID-19 outbreak in china: a modelling study

Estimating effective infection fatality rates during the course of the COVID-19 pandemic in germany

Trends in COVID-19 casefatality rates in brazilian public hospitals: A longitudinal cohort of 398,063 hospital admissions from 1st

Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy

COVID-19 mortality is negatively associated with test number and government effectiveness

Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship

Estimating case fatality rates of COVID-19

A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates

Infection fatality rate of COVID-19 inferred from seroprevalence data

Can we predict the severe course of COVID-19 -a systematic review and meta-analysis of indicators of clinical outcome?, medRxiv: The Preprint Server for Health Sciences

Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis

Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors

Infection fatality risk for SARS-CoV-2: a nationwide seroepidemiological study in the non-institutionalized population of Spain

Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis

Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?

Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis

Sars-cov-2 variant classifications and definitions

Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at

Interim estimates of increased transmissibility, growth rate, and reproduction number of the covid-19 b.1.617.2 variant of concern in the united kingdom

Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies

Rapid increase in circulation of the SARS-CoV-2 b.1.617.2 (delta) variant -mesa county, colorado

European Centre for Disease Prevention and Control, Sars-cov-2 variants of concern as of

Co-infections in people with COVID-19: a systematic review and meta-analysis

The role of co-infections and secondary infections in patients with COVID-19

Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: A test negative design

Helsinki Foundation for Human Rights

Use of masks in public places in poland during SARS-cov-2 epidemic: a covert observational study

Data, disease and diplomacy: GISAID's innovative contribution to global health

COVID-19 module in SRWE system -application and use in epidemiological surveillance and reporting to international institutions

Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

BEAST 2.5: An advanced software platform for bayesian evolutionary analysis

A Proportional Hazards Model for the Subdistribution of a Competing Risk

Regression modeling of competing risk using R: an in depth guide for clinicians

World Health Organization, Estimating mortality from covid-19

The competing risk between in-hospital mortality and recovery: A pitfall in COVID-19 survival analysis research

How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19

Estimating the case fatality ratio of the COVID-19 epidemic in China

Methods for Estimating the Case Fatality Ratio for a Novel, Emerging Infectious Disease

Competing risk analysis using R: an easy guide for clinicians

Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy

Multiple imputation of covariates by fully conditional specification: Accommodating the substantive model

smcfcs: Multiple Imputation of Covariates by Substantive Model Compatible Fully Conditional Specification

mitools: Tools for Multiple Imputation of Missing Data, r package version 2

Subdistribution Analysis of Competing Risks

Estimation of global case fatality rate of coronavirus disease 2019 (COVID-19) using meta-analyses: Comparison between calendar date and days since the outbreak of the first confirmed case

Declining covid-19 case fatality rates across all ages: analysis of german data, Tech. rep., The Centre for Evidence-Based Medicine

Age-specific COVID-19 case-fatality rate: no evidence of changes over time

Predicting SARS-CoV-2 Weather-Induced Seasonal Virulence from Atmospheric Air Enthalpy

Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients